Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

BUY
$34.5 - $42.19 $22,597 - $27,634
655 Added 2.26%
29,614 $1.25 Million
Q1 2023

Apr 28, 2023

BUY
$33.32 - $40.98 $12,395 - $15,244
372 Added 1.3%
28,959 $1.03 Million
Q4 2022

Jan 26, 2023

BUY
$25.32 - $51.45 $20,661 - $41,983
816 Added 2.94%
28,587 $0
Q3 2022

Oct 27, 2022

BUY
$46.5 - $79.14 $30,876 - $52,548
664 Added 2.45%
27,771 $1.31 Million
Q2 2022

Jul 19, 2022

BUY
$63.06 - $84.75 $74,852 - $100,598
1,187 Added 4.58%
27,107 $1.94 Million
Q1 2022

Apr 27, 2022

BUY
$74.15 - $99.36 $37,445 - $50,176
505 Added 1.99%
25,920 $2.1 Million
Q4 2021

Jan 24, 2022

BUY
$86.01 - $102.89 $58,830 - $70,376
684 Added 2.77%
25,415 $2.61 Million
Q3 2021

Oct 15, 2021

BUY
$84.7 - $96.31 $102,232 - $116,246
1,207 Added 5.13%
24,731 $2.16 Million
Q2 2021

Jul 16, 2021

BUY
$76.44 - $89.57 $100,059 - $117,247
1,309 Added 5.89%
23,524 $2.11 Million
Q1 2021

Apr 19, 2021

BUY
$67.36 - $80.76 $72,209 - $86,574
1,072 Added 5.07%
22,215 $1.69 Million
Q4 2020

Feb 01, 2021

BUY
$53.08 - $69.86 $85,087 - $111,985
1,603 Added 8.2%
21,143 $1.44 Million
Q3 2020

Oct 20, 2020

BUY
$51.29 - $65.09 $435,452 - $552,614
8,490 Added 76.83%
19,540 $1.04 Million
Q2 2020

Jul 27, 2020

BUY
$34.32 - $62.43 $4,049 - $7,366
118 Added 1.08%
11,050 $644,000
Q1 2020

Apr 27, 2020

SELL
$32.64 - $73.63 $19,681 - $44,398
-603 Reduced 5.23%
10,932 $431,000
Q4 2019

Jan 22, 2020

BUY
$48.0 - $59.55 $3,840 - $4,764
80 Added 0.7%
11,535 $686,000
Q3 2019

Oct 23, 2019

BUY
$46.64 - $55.39 $534,261 - $634,492
11,455 New
11,455 $610,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Campbell Newman Asset Management Inc Portfolio

Follow Campbell Newman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.